Enhanced Drug Delivery Device with Improved Flow Rates and Real-Time Monitoring

Publication ID: 24-11857554_0001_PTD

Published: October 28, 2025

Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Drug Delivery Device with Improved Flow Rates and Real-Time Monitoring,” Published Technical Disclosure No. 24-11857554_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857554_0001_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,554.

Summary of the Inventive Concept

An improved drug delivery device featuring a pre-assembled cartridge with modified tip geometry, integrated sensor for real-time monitoring, and enhanced mechanical discharge mechanism, addressing limitations of existing devices and providing safer, more efficient delivery of therapeutic substances.

Background and Problem Solved

The original patent disclosed a drug delivery device with a pre-assembled cartridge, but it had limitations in terms of flow rates, clogging risk, and lack of real-time monitoring. The new inventive concept addresses these limitations by introducing a modified tip geometry, integrated sensor, and enhanced mechanical discharge mechanism, ensuring more efficient and safer delivery of therapeutic substances.

Detailed Description of the Inventive Concept

The enhanced drug delivery device comprises a pre-assembled cartridge with a modified tip geometry, allowing for improved flow rates and reduced clogging risk. The device also features an integrated sensor for monitoring pressure and flow rate during delivery, providing real-time feedback to the user. The mechanical discharge mechanism is enhanced with a driver having a ratchet action and a brake for retaining a displaceable plunger, ensuring consistent and controlled delivery of the therapeutic substance. The device can be configured for single-use or multiple uses, with a replaceable delivery tip portion allowing for varying tip size and shape configurations.

Novelty and Inventive Step

The new inventive concept introduces several novel features, including the modified tip geometry, integrated sensor, and enhanced mechanical discharge mechanism, which collectively provide a significant improvement over the existing drug delivery device. The inventive step lies in the combination of these features, which address specific limitations of the original patent and provide a more efficient, safer, and more user-friendly device.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the tip geometry and material, using different types of sensors, or incorporating additional features such as temperature control or substance mixing capabilities. The device could also be adapted for use in different medical specialties or for delivering different types of therapeutic substances.

Potential Commercial Applications and Market

The enhanced drug delivery device has significant commercial potential in the medical device industry, particularly in the fields of oncology, cardiology, and neurology. The device's improved safety, efficiency, and user-friendliness make it an attractive solution for healthcare providers, and its adaptability to different medical specialties and therapeutic substances opens up a wide range of market opportunities.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically drug delivery systems and surgical intervention technologies, with expertise in mechanical design, fluid dynamics, and medical device manufacturing

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with surgical delivery mechanisms, fluid transfer technologies, and medical device regulatory requirements

Obviousness Rationale

A skilled practitioner would recognize the PTD's modifications as straightforward extensions of the source patent's core drug delivery device concept. The enhanced mechanical discharge mechanism, integrated sensor, and modified tip geometry represent predictable improvements using known techniques in medical device engineering. These variations address inherent limitations in the original design through incremental technical modifications that would be apparent to a person skilled in the art.

Obvious Combinations & Variations

Source Patent Element

Pre-assembled cartridge with perforator mechanism for substance discharge

PTD Variation

Adding integrated sensor for real-time pressure and flow rate monitoring

Obviousness Reasoning

Incorporating monitoring sensors into medical delivery devices is a known technique for improving device performance and safety, representing a predictable design enhancement

Source Patent Element

Elongate delivery tip with blunt leading end

PTD Variation

Modified tip geometry to improve flow rates and reduce clogging risk

Obviousness Reasoning

Optimizing fluid transfer geometries is a standard design approach for addressing known limitations in medical delivery systems, constituting an obvious engineering solution

Source Patent Element

Mechanical discharge mechanism with cartridge perforation

PTD Variation

Driver with ratchet action and brake for controlled substance delivery

Obviousness Reasoning

Implementing precise mechanical control mechanisms is a standard engineering approach for improving dosage consistency and user control in medical devices

Source Patent Element

Single cartridge drug delivery device

PTD Variation

Configurable for single-use or multiple uses with replaceable delivery tip

Obviousness Reasoning

Modular device design allowing component interchangeability is a predictable design evolution addressing manufacturing and user flexibility requirements

Source Patent Element

Basic drug delivery device structure

PTD Variation

Adding pretensioned spring driver for consistent flow activation

Obviousness Reasoning

Implementing standardized mechanical actuation methods represents a known technique for improving device reliability and performance in medical delivery systems

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this publication would have been obvious to a person having ordinary skill in the art at the time of invention, with a reasonable expectation of success, when considered in light of US Patent 11857554. The incremental technical modifications represent predictable engineering solutions that do not rise to the level of non-obvious innovation, thereby establishing this disclosure as valid prior art against potential future patent claims in the drug delivery device domain.

Original Patent Information

Patent Number	US 11,857,554
Title	Drug delivery device with pre-assembled cartridge
Assignee(s)	INTRAVITAL PTY LTD.